University of Salerno-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2023

  1. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products

    Clinical and experimental rheumatology, Vol. 41, Núm. 3, pp. 543-553

2021

  1. Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

    Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491

2020

  1. Characteristics and treatment regimens across ERS SHARP severe asthma registries

    European Respiratory Journal, Vol. 55, Núm. 1

  2. Impact of caloric restriction on AMPK and endoplasmic reticulum stress in peripheral tissues and circulating peripheral blood mononuclear cells from Zucker rats

    Journal of Nutritional Biochemistry, Vol. 78

2017

  1. Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis

    American Heart Journal, Vol. 193, pp. 46-54

  2. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis

    Clinical Microbiology and Infection, Vol. 23, Núm. 8, pp. 544-549

  3. Prosthetic joints: shining lights on challenging blind spots

    International Journal of Antimicrobial Agents

2016

  1. Clinical, neuroradiological and molecular characterization of cerebellar dysplasia with cysts (Poretti-Boltshauser syndrome)

    European Journal of Human Genetics, Vol. 24, Núm. 9, pp. 1262-1267

  2. Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials

    Cardiovascular Revascularization Medicine, Vol. 17, Núm. 5, pp. 295-301

2015

  1. Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis

    Heart, Vol. 101, Núm. 19, pp. 1554-1561

  2. Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: A patient-level analysis of the randomized early routine invasive clinical trials

    JACC: Cardiovascular Interventions, Vol. 8, Núm. 1, pp. 166-174

2014

  1. Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials

    American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3

2013

  1. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort

    PLoS ONE, Vol. 8, Núm. 5

  2. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke

    Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 209-217